Transcriptomics

Dataset Information

0

Airway epithelial cells from smokers treated with myo-inositol or placebo


ABSTRACT: Samples were obtained as part of a randomized, double blind, placebo-controlled, phase IIb study to determine the effects of myo-inositol in smokers with bronchial dysplasia. Smokers with greater than 1 site of dysplasia identified by autofluorescence bronchoscopy-directed biopsy were randomly assigned to receive oral placebo or myo-inositol, 9 g once/day for two weeks and then twice/day for 6 months. Cytologically normal airway epithelial cells were obtained via bronchoscopy from the right or left mainstem bronchus at baseline and 6 months post-treatment with myo-inositol or placebo from 69 study participants (n=138 samples). The RNA from these samples was isolated and used to prepare libraries for mRNA sequencing. Subjects were classified by response according to their change in dysplasia rate after 6-months. Among subjects with a complete response in the myo-inositol arm, there was a significant decrease in a gene expression signature reflective of PI3K activation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE86422 | GEO | 2016/09/26

SECONDARY ACCESSION(S): PRJNA341833

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-04-11 | E-GEOD-12815 | biostudies-arrayexpress
| PRJNA341833 | ENA
2010-04-12 | GSE12815 | GEO
2022-12-19 | GSE143434 | GEO
2022-12-19 | GSE143433 | GEO
2022-12-19 | GSE143427 | GEO
2014-10-31 | E-GEOD-33479 | biostudies-arrayexpress
2023-09-21 | GSE240001 | GEO
2023-09-21 | GSE240000 | GEO
2013-12-03 | E-GEOD-45287 | biostudies-arrayexpress